申请人:PTC THERAPEUTICS INC
公开号:WO2023028534A1
公开(公告)日:2023-03-02
The present invention relates to novel compounds of Formulae I-XI: wherein each A, A', Q, Q', W, Rw, Y, and Z, and -- are as defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention further relates to the processes for their preparation, pharmaceutical compositions and medicaments containing them, and their use in the treatment of diseases and disorders mediated by NLRP3.
本发明涉及公式I-XI的新化合物:其中每个A、A'、Q、Q'、W、Rw、Y和Z以及-如本文所定义,它们抑制NOD样受体蛋白3(NLRP3)炎性小体活性。本发明还涉及它们的制备过程、含有它们的制药组合物和药物以及它们在治疗由NLRP3介导的疾病和紊乱中的应用。